Epstein Secrets

nated by holders of our common stock; Mr. Botha was elected as the designee nominated by holders of our Series B convertible preferred stock; • Ms. Meeker was elected as the designee nominated by holders of our Series C convertible preferred stock; and • Mr. Viniar was elected as a designee nominated b

-year terms. Our current directors will be divided among the three classes as follows: • the Class I directors will be Messrs. Dorsey, Johnson, and Viniar, and their terms will expire at the annual meeting of stockholders to be held in 2016: • the Class II directors will be Messrs. Botha and McKelvey

B convertible preferred stock; • Ms. Meeker was elected as the designee nominated by holders of our Series C convertible preferred stock; and • Mr. Viniar was elected as a designee nominated by holders of a majority of each of our common stock and our convertible preferred stock. In connection with th

elvey was selected to serve on our board of directors because of the perspective and experience he brings as one of our founders. Mary Meeker. Ms. Meeker has served as a member of our board of directors since June 2011. Since December 2010, Ms. Meeker has served as a General Partner of Kleiner Perkins

from Harvard University. Dr. Summers was selected to serve on our board of directors because of his extensive policy experience. David Viniar. Mr. Viniar has served as a member of our board of directors since October 2013. From August 1980 until his retirement in January 2013, Mr. Viniar served in var

S- I/A serving on our board of directors or compensation committee. Ms. Meeker, a General Partner of Kleiner Perkins Caufield & Byers, and Mr. Botha. a Managing Member of Sequoia Capital, comprise our compensation committee. En

mmers' continued service with us. As of December 31, 2014, Dr. Summers held 161,000 restricted shares of our common stock. On October 30, 2013, Mr. Viniar was granted an option to purchase 326,950 shares of our common stock. This option is early exercisable. One-fourth of the shares subject to the opti